Cencora, Inc. - Investor Relations

Corporate overview

Cencora, formerly AmerisourceBergen, is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers, and pharmacies to improve product access and efficiency throughout the healthcare supply chain.

Latest quarterly results

See all quarters

Financial highlights

FY26 Revenue

Pharmaceutical Distribution & Services: $284,484M
Specialty Pharmaceutical & Provider Services: $45,390M
Other: $8,739M

1. Includes $1,217M and $9M of intrasegment revenue and operating income eliminations, respectively.
2. Cencora recently completed a restructuring of its operating model intended to strengthen execution and improve visibility. As a result of this restructuring, the Company has reorganized all business components within the U.S. Healthcare Solutions and International Healthcare Solutions reportable segments. Beginning in the first quarter of fiscal 2027, the Company’s reporting structure will be comprised of Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other. For further detail on fiscal 2026 revised reportable segment information, please reference the Company's 8-K furnished on November 4, 2026.

FY26 Adjusted operating income

Pharmaceutical Distribution & Services: $2,736M
Specialty Pharmaceutical & Provider Services: $1,693M
Other: $393M

3. FY26 GAAP Operating Income of $3,930M. For more information and a reconciliation of non-GAAP financial measures, refer to the Company's Current Report on Form 8-K furnished under item 2.02 on November 4, 2026.

Cencora: By the numbers

$300B+

Annual revenue

51,000+

Team Members

150+

Global offices

Summary Annual Report

Recent news

See all news

Events and presentations

See all events

Notice Of Pendency And Proposed Settlement Of Stockholder Derivative Action, Settlement Hearing, And Right To Appear

Stipulation of Settlement

Cencora stockholder derivative litigation